Asian Spectator

Men's Weekly

.

TÜV SÜD Appoints Interim Leadership Following CEO Transition

MUNICH, GERMANY – NEWSAKTUELL - 10 July 2025 - The Supervisory Board of TÜV SÜD AG has appointed Ishan Palit, former Asia Pacific CEO, as Interim Chief Executive Officer (Chairman of ...

Via raises Series E financing to expand access to efficient, s...

NEW YORK, March 31, 2020 /PRNewswire-AsiaNet/ -- -- John Elkann, Chairman and CEO of EXOR, lead investor in the financing: "More important than ever to work for an innovative and sustainable...

XCMG Brings its Largest Exhibition to CONEXPO-CON/AGG 2020

LAS VEGAS, March 4, 2020 /PRNewswire-AsiaNet/ -- Leading Chinese construction machinery manufacturer XCMG (SHE: 000425) is delivering a comprehensive array of 24 flagship products to CONEXPO...

China Marketing Book Digital China: Working with Bloggers, Influencers and KOLs offers social media insights to US marketers

HONG KONG, CHINA - Media OutReach - 5 NOV 2018 - Marketers who have struggled to capitalize on their Chinese social media presence can rest easy, with the launch of new book Digital China: W...

Zoomlion: Building a Sustainable Future with Green, Intelligen...

CHANGSHA, China, April 28, 2022 /PRNewswire-AsiaNet/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion"; 1157.HK), a leading high-end equipment manufacturing enterpris...

New global call to recruit ambassadors of the Liangzhu culture

HANGZHOU, China, Oct. 14, 2019 /PRNewswire-AsiaNet/ -- - The ancient city of Liangzhu, an emerging popular landmark located in China's Zhejiang province, has, to date, welcomed 130,000 visit...

Virtuos Deepens Video Game Engineering Capabilities With the Launch of Virtuos Labs - Montpellier

Virtuos Labs commits to best-in-class research and development of game engines, graphics, and tools to solve advanced technical and complex projectsSINGAPORE - Media OutReach - 26 October 2...

Winners of the FMC 2021 International Scoring Competition Are Already Known

LONDON, Oct 11, 2021 - (ACN Newswire) - On October 3 & 5 FMC- Film Music Contest & Awards 2021 announced the winners of all categories of the competition.FMC is annually organized p...

LONGi Released New Series of High-Power Modules - 430W Hi-MO4 ...

XI'AN, China, May 15,2019/PRNewswire-AsiaNet/-- Highlighting its growing strength in the industry, LONGi has released a new series of modules that set an industry benchmark - the new generat...

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

SYDNEY, Apr 8, 2020 - (ACN Newswire) - Asia-Pacific's largest specialist biotech CRO Novotech said the top 10 biotech sites in Australia were open for clinical trial activity with many sites modifying their practices to ensure continuity of operations.

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

View and Download the COVID-19 Australia Data Bulletin here. https://novotech-cro.com/covid-19-notice

The data is part of a new series prepared for Novotech clients detailing the current status of trials in the Asia-Pacific during the global COVID-19 crisis.

Novotech CEO Dr John Moller said the Bulletin series taps local knowledge of fundamentals in the sector and shows which countries in the region are able to support clinical research for Novotech and its clients during this time.

"While the situation is always evolving, Australia appears to be managing the crisis well. Our sites have changed how they manage trials in line with Australian Government health guidelines and most are still able to deliver the clinical trial services we need for our clients," said Dr Moller. "Study delays caused by COVID-19 can be rapidly addressed by activating new sites in Australia and Asia."

Australia has attractive start-up times, world leading investigators and research teams, and valuable rebates of up to 43.5% on clinical trial spend.

About Novotech

Novotech, established in 1996, is internationally recognized as the leading full-service contract research organization (CRO) in Asia-Pacific. Novotech provides clinical development services across all clinical trial phases and therapeutic areas and has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotech companies.

Novotech obtained the ISO 27001, the best-known standard in the ISO family, providing the requirements for an Information Security Management System. Together with the ISO 9001 Quality Management system, Novotech aims at the highest IT security and quality standards for patients and biotechnology companies. Visit http://novotech-cro.com.

For RFP enquiries: Please fill out the form available at https://novotech-cro.com/talk-to-an-expert

Media ContactSusan Fitzpatrick-Napiercommunications@novotech-cro.comAU: +61 2 8218 2144 USA: +1 415 951 3228Asia: +65 3159 3427

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Cara membahas masalah tanpa menimbulkan pertengkaran: Tip dari ahli

Pormezz / ShutterstockKita sebagai manusia memiliki perbedaan satu sama lain yang memengaruhi pendapat kita. Maka dari itu, ada kalanya kita tidak setuju dengan pendapat orang lain.Berbeda pendapat ka...

Diplomasi emosional: Bagaimana rasa marah dan takut dapat membentuk arah kebijakan global

Gambar Perdana Menteri Israel Benjamin Netanyahu (kiri) dan Pemimpin Tertinggi Iran Ayatollah Ali Khamenei di layar, merefleksikan perang antara Iran dan Israel.Mmiss.cabul/Shutterstock● Memanas...

Riset: Populasi hewan langka anoa dan babirusa di pulau kecil lebih tangguh, meski jumlahnya sedikit

● Populasi satwa di pulau kecil terbukti lebih tangguh secara genetik meski jumlahnya sedikit.● Pulau kecil dapat menjadi habitat alami yang penting bagi kelangsungan hewan langka.● ...